S. Fouda

A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants

Teddy J. Akiki, J. Krystal, J. Deakin, 2019, iScience.

WHO EMRO | Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures

Ahmed Negida, A. Abushouk, M. Kelany, 2018 .

Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures.

Ahmed Negida, A. Abushouk, M. Kelany, 2018, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence.

Lynnette A. Averill, C. Abdallah, J. Murrough, 2020, Advances in pharmacology.

Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder

Teddy J. Akiki, Lynnette A. Averill, C. Abdallah, 2020, Chronic stress.

Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

Ahmed Negida, Gehad El Ashal, A. Menshawy, 2016, CNS & neurological disorders drug targets.

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Lynnette A. Averill, D. Mathalon, J. Krystal, 2020, Neuropsychopharmacology.

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

Ahmed Elmaraezy, A. Abushouk, Ammar M. AlSafadi, 2017, BMC Neurology.

mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.

S. Southwick, J. Krystal, R. Gueorguieva, 2022, Journal of affective disorders.